Get the Stockscreener App
21.18
3.51%
-0.77
After Hours:
21.02
-0.16
-0.76%
Amphastar Pharmaceuticals Inc stock is traded at $21.18, with a volume of 504.34K.
It is down -3.51% in the last 24 hours and down -17.97% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$21.95
Open:
$22.11
24h Volume:
504.34K
Relative Volume:
0.94
Market Cap:
$998.41M
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
7.06
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
-6.28%
1M Performance:
-17.97%
6M Performance:
-41.56%
1Y Performance:
-45.36%
1-Day Range:
$21.16
$22.31
1-Week Range:
$21.16
$22.94
52-Week Range:
$21.16
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
21.18 | 1.07B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
152.86 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.75 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.73 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.04 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.24 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines
How Amphastar Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
Amphastar stock hits 52-week low at $21.47 amid challenging year - Investing.com Canada
Why Amphastar Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser
Amphastar to quadruple production capacity at California headquarters By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - ACCESS Newswire
Amphastar Plans Massive 4X Production Boost: Major US Pharma Manufacturing Expansion Coming by 2028 - Stock Titan
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowWhat's Next? - MarketBeat
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
55,795 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by SteelPeak Wealth LLC - MarketBeat
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - TradingView
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Cambridge Investment Research Advisors Inc. - Defense World
Allspring Global Investments Holdings LLC Has $434,000 Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowHere's Why - MarketBeat
JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30 - MSN
13 Cheap Healthcare Stocks with Huge Upside Potential - Insider Monkey
Floyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Illinois Municipal Retirement Fund Sells 604 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions - TradingView
(AMPH) On The My Stocks Page - news.stocktradersdaily.com
State of Alaska Department of Revenue Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Naloxone Market Is Booming So Rapidly 2025-2032 -Viatris Inc., - openPR.com
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Trust Walden Corp Acquires 236,704 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
GAMMA Investing LLC Purchases 37,735 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Rhumbline Advisers Increases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
GAMMA Investing LLC Has $1.12 Million Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
CX Institutional Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Bridge City Capital LLC Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Where are the Opportunities in (AMPH) - news.stocktradersdaily.com
AMPH Q1 Earnings Call: Product Mix Shift and Margin Pressures Highlight Competitive Challenges - Yahoo Finance
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals? - simplywall.st
California State Teachers Retirement System Sells 595 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,835.00 in Stock - MarketBeat
Wellington Management Group LLP Trims Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Rises By 24.9% - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.09 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Squarepoint Ops LLC Has $656,000 Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth By Investing.com - Investing.com Canada
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):